Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 16Thoracic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 35Lung Neoplasms 12Neoplasm Metastasis 10Carcinoma, Renal Cell 10Carcinoma, Non-Small-Cell Lung 10Lymphoma, T-Cell, Cutaneous 6Breast Neoplasms 6Brain Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Colorectal Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Merkel Cell 5Carcinoma, Hepatocellular 5Uveal Melanoma 4Thyroid Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Mycosis Fungoides 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4Carcinoma, Basal Cell 4Waldenstrom Macroglobulinemia 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma, Kaposi 3Prostatic Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, T-Cell 3

Interventions

pembrolizumab 1motexafin gadolinium 1cabozantinib 1Taxes 1Specimen Handling 1Ritonavir 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Indinavir 1Doxorubicin 1Cisplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypopharyngeal Neoplasms × Magnetic Resonance Spectroscopy × Dermatologic × Clear all
NCT05136196 2026-06-05

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡